BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32128793)

  • 1. Short- and long-term mortality after liver transplantation in patients with and without hepatocellular carcinoma in the UK.
    Wallace D; Cowling TE; Walker K; Suddle A; Rowe I; Callaghan C; Gimson A; Bernal W; Heaton N; van der Meulen J
    Br J Surg; 2020 Jun; 107(7):896-905. PubMed ID: 32128793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National time trends in mortality and graft survival following liver transplantation from circulatory death or brainstem death donors.
    Wallace D; Cowling TE; Suddle A; Gimson A; Rowe I; Callaghan C; Sapisochin G; Ivanics T; Claasen M; Mehta N; Heaton N; van der Meulen J; Walker K
    Br J Surg; 2021 Dec; 109(1):79-88. PubMed ID: 34738095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation outcomes after transarterial chemotherapy for hepatocellular carcinoma.
    Wallace D; Cowling TE; Walker K; Suddle A; Gimson A; Rowe I; Callaghan C; Sapisochin G; Mehta N; Heaton N; van der Meulen J
    Br J Surg; 2020 Aug; 107(9):1183-1191. PubMed ID: 32222049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Impact of Suboptimal Donor Characteristics on Mortality After Liver Transplantation: A Time-dependent Analysis Comparing HCC With Non-HCC Patients.
    Wallace D; Walker K; Charman S; Suddle A; Gimson A; Rowe I; Callaghan C; Cowling T; Heaton N; van der Meulen J
    Transplantation; 2019 Apr; 103(4):e89-e98. PubMed ID: 30747843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.
    Orci LA; Berney T; Majno PE; Lacotte S; Oldani G; Morel P; Mentha G; Toso C
    Br J Surg; 2015 Sep; 102(10):1250-7. PubMed ID: 26098966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts.
    Croome KP; Wall W; Chandok N; Beck G; Marotta P; Hernandez-Alejandro R
    Liver Transpl; 2013 Nov; 19(11):1214-23. PubMed ID: 23907778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Rich N; Tanriover B; Singal AG; Marrero JA
    Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Donation After Cardiac Death Utilization Adversely Affect Hepatocellular Cancer Survival?
    Khorsandi SE; Yip VS; Cortes M; Jassem W; Quaglia A; O'Grady J; Heneghan M; Aluvihare V; Agarwal K; Menon K; Vilca-Melendez H; Prachalias A; Srinivasan P; Suddle A; Rela M; Heaton N
    Transplantation; 2016 Sep; 100(9):1916-24. PubMed ID: 26982954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Time-Dependent Impact of Performance Status on Outcomes After Liver Transplantation.
    Wallace D; Cowling T; McPhail MJ; Brown SE; Aluvihare V; Suddle A; Auzinger G; Heneghan MA; Rowe IA; Walker K; Heaton N; van der Meulen J; Bernal W
    Hepatology; 2020 Oct; 72(4):1341-1352. PubMed ID: 31968130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-liver transplant survival in hepatitis C patients is improving over time.
    O'Leary JG; Randall H; Onaca N; Jennings L; Klintmalm GB; Davis GL
    Liver Transpl; 2009 Apr; 15(4):360-8. PubMed ID: 19326409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry.
    Jay C; Ladner D; Wang E; Lyuksemburg V; Kang R; Chang Y; Feinglass J; Holl JL; Abecassis M; Skaro AI
    J Hepatol; 2011 Oct; 55(4):808-13. PubMed ID: 21338639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
    Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry.
    Sehjal J; Sharples LD; Keogh RH; Walker K; Prachalias A; Heaton N; Ivanics T; van der Meulen J; Wallace D
    Transplantation; 2022 Nov; 106(11):e464-e475. PubMed ID: 36017919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients.
    Salgia RJ; Goodrich NP; Marrero JA; Volk ML
    Dig Dis Sci; 2014 Jan; 59(1):214-9. PubMed ID: 24077924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recipient obesity does not affect survival after deceased donor liver transplantation for hepatocellular carcinoma. A national retrospective cohort study in the United States.
    Ata N; Ayloo S; Tsung A; Molinari M
    HPB (Oxford); 2019 Jan; 21(1):67-76. PubMed ID: 30691592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China.
    Chen J; Yang Z; Gao F; Zhou Z; Chen J; Lu D; Wang K; Sui M; Wang Z; Guo W; Lyu G; Qi H; Cai J; Yang J; Zheng S; Xu X
    Cancer Biol Med; 2024 Feb; 21(4):347-62. PubMed ID: 38425217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pattern of late mortality in liver transplant recipients in the United Kingdom.
    Gelson W; Hoare M; Dawwas MF; Vowler S; Gibbs P; Alexander G
    Transplantation; 2011 Jun; 91(11):1240-4. PubMed ID: 21516069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.